Trade Wars & Tariffs

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Prop trading firm Topstep partners with skier Alex Ferreira for a major rebrand, a new ad campaign, and an expanded ecosystem for retail traders.

MapleTech's new Aspire Quick Start tool uses AI to cut underwriting from hours to minutes, offering a lifeline to an industry desperate for a turnaround.

Life science REIT giant Alexandria Real Estate Equities is raising $750M in new debt. We dive into the strategic move to manage its finances amid market headwinds.

With a new CRO from Zoom, LastPass aims to accelerate its B2B strategy, targeting the complex security challenges of the modern SaaS and AI-driven enterprise.

Capitol AI appoints Chester Leung as VP of Engineering, signaling a major push to embed security and governance at the core of its enterprise platform.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

With a new CEO from the plaintiff legal world, Practice Made Perfect aims to scale its unique model for law firm growth in an increasingly competitive market.

Cloud communications firm RingCentral will join the S&P SmallCap 600, triggering investment shifts and highlighting tech's growing market influence.

A landmark study of 2.8 million people unpacks the complex causes of food allergies, vindicates vaccines, and offers parents clarity on what they can control.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

The era of rapid, uniform skyscraper growth is over. A new report reveals a global shift to selective development amid economic and geopolitical pressures.

AB Science's Masivet gets key FDA designation, paving the way for a new targeted cancer therapy for dogs and a major strategic win for the company.

Hong Kong publisher Jimmy Lai, 78, receives a 20-year sentence, decried as a 'life sentence' and a grave threat to journalists worldwide.

A major defense order for infrared cameras highlights LightPath's strategic growth and the critical push for secure, domestic military manufacturing.

Retired Four-Star General Jack Keane joins REalloys to build a US rare earth supply chain, as a fintech firm pivots to tackle national security risks.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.